Global Radiopharmaceutical Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Radiopharmaceutical. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Radiopharmaceutical market.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.
Key Features:
The report on Radiopharmaceutical market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Radiopharmaceutical market. It may include historical data, market segmentation by Type (e.g., Actinium-225, Lutetium-177), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Radiopharmaceutical market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Radiopharmaceutical market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Radiopharmaceutical industry. This include advancements in Radiopharmaceutical technology, Radiopharmaceutical new entrants, Radiopharmaceutical new investment, and other innovations that are shaping the future of Radiopharmaceutical.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Radiopharmaceutical market. It includes factors influencing customer ' purchasing decisions, preferences for Radiopharmaceutical product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Radiopharmaceutical market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Radiopharmaceutical market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Radiopharmaceutical market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Radiopharmaceutical industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Radiopharmaceutical market.
Market Segmentation:
Radiopharmaceutical market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Radiopharmaceutical market?
What factors are driving Radiopharmaceutical market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceutical market opportunities vary by end market size?
How does Radiopharmaceutical break out type, application?
According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Radiopharmaceutical. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Radiopharmaceutical market.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.
Key Features:
The report on Radiopharmaceutical market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Radiopharmaceutical market. It may include historical data, market segmentation by Type (e.g., Actinium-225, Lutetium-177), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Radiopharmaceutical market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Radiopharmaceutical market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Radiopharmaceutical industry. This include advancements in Radiopharmaceutical technology, Radiopharmaceutical new entrants, Radiopharmaceutical new investment, and other innovations that are shaping the future of Radiopharmaceutical.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Radiopharmaceutical market. It includes factors influencing customer ' purchasing decisions, preferences for Radiopharmaceutical product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Radiopharmaceutical market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Radiopharmaceutical market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Radiopharmaceutical market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Radiopharmaceutical industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Radiopharmaceutical market.
Market Segmentation:
Radiopharmaceutical market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
- Oncology
- Cardiology
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
What is the 10-year outlook for the global Radiopharmaceutical market?
What factors are driving Radiopharmaceutical market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceutical market opportunities vary by end market size?
How does Radiopharmaceutical break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Radiopharmaceutical by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Radiopharmaceutical by Country/Region, 2019, 2023 & 2030
2.2 Radiopharmaceutical Segment by Type
2.2.1 Actinium-225
2.2.2 Lutetium-177
2.2.3 Radium-223
2.2.4 Holmium-166
2.2.5 Other
2.3 Radiopharmaceutical Sales by Type
2.3.1 Global Radiopharmaceutical Sales Market Share by Type (2019-2024)
2.3.2 Global Radiopharmaceutical Revenue and Market Share by Type (2019-2024)
2.3.3 Global Radiopharmaceutical Sale Price by Type (2019-2024)
2.4 Radiopharmaceutical Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical Sales by Application
2.5.1 Global Radiopharmaceutical Sale Market Share by Application (2019-2024)
2.5.2 Global Radiopharmaceutical Revenue and Market Share by Application (2019-2024)
2.5.3 Global Radiopharmaceutical Sale Price by Application (2019-2024)
3 GLOBAL RADIOPHARMACEUTICAL BY COMPANY
3.1 Global Radiopharmaceutical Breakdown Data by Company
3.1.1 Global Radiopharmaceutical Annual Sales by Company (2019-2024)
3.1.2 Global Radiopharmaceutical Sales Market Share by Company (2019-2024)
3.2 Global Radiopharmaceutical Annual Revenue by Company (2019-2024)
3.2.1 Global Radiopharmaceutical Revenue by Company (2019-2024)
3.2.2 Global Radiopharmaceutical Revenue Market Share by Company (2019-2024)
3.3 Global Radiopharmaceutical Sale Price by Company
3.4 Key Manufacturers Radiopharmaceutical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceutical Product Location Distribution
3.4.2 Players Radiopharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceutical Market Size by Geographic Region (2019-2024)
4.1.1 Global Radiopharmaceutical Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Radiopharmaceutical Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Radiopharmaceutical Market Size by Country/Region (2019-2024)
4.2.1 Global Radiopharmaceutical Annual Sales by Country/Region (2019-2024)
4.2.2 Global Radiopharmaceutical Annual Revenue by Country/Region (2019-2024)
4.3 Americas Radiopharmaceutical Sales Growth
4.4 APAC Radiopharmaceutical Sales Growth
4.5 Europe Radiopharmaceutical Sales Growth
4.6 Middle East & Africa Radiopharmaceutical Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceutical Sales by Country
5.1.1 Americas Radiopharmaceutical Sales by Country (2019-2024)
5.1.2 Americas Radiopharmaceutical Revenue by Country (2019-2024)
5.2 Americas Radiopharmaceutical Sales by Type
5.3 Americas Radiopharmaceutical Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical Sales by Region
6.1.1 APAC Radiopharmaceutical Sales by Region (2019-2024)
6.1.2 APAC Radiopharmaceutical Revenue by Region (2019-2024)
6.2 APAC Radiopharmaceutical Sales by Type
6.3 APAC Radiopharmaceutical Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceutical by Country
7.1.1 Europe Radiopharmaceutical Sales by Country (2019-2024)
7.1.2 Europe Radiopharmaceutical Revenue by Country (2019-2024)
7.2 Europe Radiopharmaceutical Sales by Type
7.3 Europe Radiopharmaceutical Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical by Country
8.1.1 Middle East & Africa Radiopharmaceutical Sales by Country (2019-2024)
8.1.2 Middle East & Africa Radiopharmaceutical Revenue by Country (2019-2024)
8.2 Middle East & Africa Radiopharmaceutical Sales by Type
8.3 Middle East & Africa Radiopharmaceutical Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceutical
10.3 Manufacturing Process Analysis of Radiopharmaceutical
10.4 Industry Chain Structure of Radiopharmaceutical
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceutical Distributors
11.3 Radiopharmaceutical Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceutical Market Size Forecast by Region
12.1.1 Global Radiopharmaceutical Forecast by Region (2025-2030)
12.1.2 Global Radiopharmaceutical Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiopharmaceutical Forecast by Type
12.7 Global Radiopharmaceutical Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bracco Imaging
13.1.1 Bracco Imaging Company Information
13.1.2 Bracco Imaging Radiopharmaceutical Product Portfolios and Specifications
13.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bracco Imaging Main Business Overview
13.1.5 Bracco Imaging Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Radiopharmaceutical Product Portfolios and Specifications
13.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Radiopharmaceutical Product Portfolios and Specifications
13.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Nordion
13.4.1 Nordion Company Information
13.4.2 Nordion Radiopharmaceutical Product Portfolios and Specifications
13.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Nordion Main Business Overview
13.4.5 Nordion Latest Developments
13.5 Triad Isotopes
13.5.1 Triad Isotopes Company Information
13.5.2 Triad Isotopes Radiopharmaceutical Product Portfolios and Specifications
13.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Triad Isotopes Main Business Overview
13.5.5 Triad Isotopes Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Radiopharmaceutical Product Portfolios and Specifications
13.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 IBA Group
13.7.1 IBA Group Company Information
13.7.2 IBA Group Radiopharmaceutical Product Portfolios and Specifications
13.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 IBA Group Main Business Overview
13.7.5 IBA Group Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Radiopharmaceutical Product Portfolios and Specifications
13.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
13.9 China Isotope & Radiation
13.9.1 China Isotope & Radiation Company Information
13.9.2 China Isotope & Radiation Radiopharmaceutical Product Portfolios and Specifications
13.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 China Isotope & Radiation Main Business Overview
13.9.5 China Isotope & Radiation Latest Developments
13.10 Jubilant Pharma
13.10.1 Jubilant Pharma Company Information
13.10.2 Jubilant Pharma Radiopharmaceutical Product Portfolios and Specifications
13.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Jubilant Pharma Main Business Overview
13.10.5 Jubilant Pharma Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly Radiopharmaceutical Product Portfolios and Specifications
13.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Advanced Accelerator Applications
13.12.1 Advanced Accelerator Applications Company Information
13.12.2 Advanced Accelerator Applications Radiopharmaceutical Product Portfolios and Specifications
13.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Advanced Accelerator Applications Main Business Overview
13.12.5 Advanced Accelerator Applications Latest Developments
13.13 SIEMENS
13.13.1 SIEMENS Company Information
13.13.2 SIEMENS Radiopharmaceutical Product Portfolios and Specifications
13.13.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 SIEMENS Main Business Overview
13.13.5 SIEMENS Latest Developments
13.14 Dongcheng
13.14.1 Dongcheng Company Information
13.14.2 Dongcheng Radiopharmaceutical Product Portfolios and Specifications
13.14.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Dongcheng Main Business Overview
13.14.5 Dongcheng Latest Developments
13.15 Navidea
13.15.1 Navidea Company Information
13.15.2 Navidea Radiopharmaceutical Product Portfolios and Specifications
13.15.3 Navidea Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Navidea Main Business Overview
13.15.5 Navidea Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Radiopharmaceutical by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Radiopharmaceutical by Country/Region, 2019, 2023 & 2030
2.2 Radiopharmaceutical Segment by Type
2.2.1 Actinium-225
2.2.2 Lutetium-177
2.2.3 Radium-223
2.2.4 Holmium-166
2.2.5 Other
2.3 Radiopharmaceutical Sales by Type
2.3.1 Global Radiopharmaceutical Sales Market Share by Type (2019-2024)
2.3.2 Global Radiopharmaceutical Revenue and Market Share by Type (2019-2024)
2.3.3 Global Radiopharmaceutical Sale Price by Type (2019-2024)
2.4 Radiopharmaceutical Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical Sales by Application
2.5.1 Global Radiopharmaceutical Sale Market Share by Application (2019-2024)
2.5.2 Global Radiopharmaceutical Revenue and Market Share by Application (2019-2024)
2.5.3 Global Radiopharmaceutical Sale Price by Application (2019-2024)
3 GLOBAL RADIOPHARMACEUTICAL BY COMPANY
3.1 Global Radiopharmaceutical Breakdown Data by Company
3.1.1 Global Radiopharmaceutical Annual Sales by Company (2019-2024)
3.1.2 Global Radiopharmaceutical Sales Market Share by Company (2019-2024)
3.2 Global Radiopharmaceutical Annual Revenue by Company (2019-2024)
3.2.1 Global Radiopharmaceutical Revenue by Company (2019-2024)
3.2.2 Global Radiopharmaceutical Revenue Market Share by Company (2019-2024)
3.3 Global Radiopharmaceutical Sale Price by Company
3.4 Key Manufacturers Radiopharmaceutical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceutical Product Location Distribution
3.4.2 Players Radiopharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceutical Market Size by Geographic Region (2019-2024)
4.1.1 Global Radiopharmaceutical Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Radiopharmaceutical Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Radiopharmaceutical Market Size by Country/Region (2019-2024)
4.2.1 Global Radiopharmaceutical Annual Sales by Country/Region (2019-2024)
4.2.2 Global Radiopharmaceutical Annual Revenue by Country/Region (2019-2024)
4.3 Americas Radiopharmaceutical Sales Growth
4.4 APAC Radiopharmaceutical Sales Growth
4.5 Europe Radiopharmaceutical Sales Growth
4.6 Middle East & Africa Radiopharmaceutical Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceutical Sales by Country
5.1.1 Americas Radiopharmaceutical Sales by Country (2019-2024)
5.1.2 Americas Radiopharmaceutical Revenue by Country (2019-2024)
5.2 Americas Radiopharmaceutical Sales by Type
5.3 Americas Radiopharmaceutical Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical Sales by Region
6.1.1 APAC Radiopharmaceutical Sales by Region (2019-2024)
6.1.2 APAC Radiopharmaceutical Revenue by Region (2019-2024)
6.2 APAC Radiopharmaceutical Sales by Type
6.3 APAC Radiopharmaceutical Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceutical by Country
7.1.1 Europe Radiopharmaceutical Sales by Country (2019-2024)
7.1.2 Europe Radiopharmaceutical Revenue by Country (2019-2024)
7.2 Europe Radiopharmaceutical Sales by Type
7.3 Europe Radiopharmaceutical Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical by Country
8.1.1 Middle East & Africa Radiopharmaceutical Sales by Country (2019-2024)
8.1.2 Middle East & Africa Radiopharmaceutical Revenue by Country (2019-2024)
8.2 Middle East & Africa Radiopharmaceutical Sales by Type
8.3 Middle East & Africa Radiopharmaceutical Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceutical
10.3 Manufacturing Process Analysis of Radiopharmaceutical
10.4 Industry Chain Structure of Radiopharmaceutical
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceutical Distributors
11.3 Radiopharmaceutical Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICAL BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceutical Market Size Forecast by Region
12.1.1 Global Radiopharmaceutical Forecast by Region (2025-2030)
12.1.2 Global Radiopharmaceutical Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiopharmaceutical Forecast by Type
12.7 Global Radiopharmaceutical Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bracco Imaging
13.1.1 Bracco Imaging Company Information
13.1.2 Bracco Imaging Radiopharmaceutical Product Portfolios and Specifications
13.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bracco Imaging Main Business Overview
13.1.5 Bracco Imaging Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Radiopharmaceutical Product Portfolios and Specifications
13.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Radiopharmaceutical Product Portfolios and Specifications
13.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Nordion
13.4.1 Nordion Company Information
13.4.2 Nordion Radiopharmaceutical Product Portfolios and Specifications
13.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Nordion Main Business Overview
13.4.5 Nordion Latest Developments
13.5 Triad Isotopes
13.5.1 Triad Isotopes Company Information
13.5.2 Triad Isotopes Radiopharmaceutical Product Portfolios and Specifications
13.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Triad Isotopes Main Business Overview
13.5.5 Triad Isotopes Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Radiopharmaceutical Product Portfolios and Specifications
13.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 IBA Group
13.7.1 IBA Group Company Information
13.7.2 IBA Group Radiopharmaceutical Product Portfolios and Specifications
13.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 IBA Group Main Business Overview
13.7.5 IBA Group Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Radiopharmaceutical Product Portfolios and Specifications
13.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
13.9 China Isotope & Radiation
13.9.1 China Isotope & Radiation Company Information
13.9.2 China Isotope & Radiation Radiopharmaceutical Product Portfolios and Specifications
13.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 China Isotope & Radiation Main Business Overview
13.9.5 China Isotope & Radiation Latest Developments
13.10 Jubilant Pharma
13.10.1 Jubilant Pharma Company Information
13.10.2 Jubilant Pharma Radiopharmaceutical Product Portfolios and Specifications
13.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Jubilant Pharma Main Business Overview
13.10.5 Jubilant Pharma Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly Radiopharmaceutical Product Portfolios and Specifications
13.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Advanced Accelerator Applications
13.12.1 Advanced Accelerator Applications Company Information
13.12.2 Advanced Accelerator Applications Radiopharmaceutical Product Portfolios and Specifications
13.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Advanced Accelerator Applications Main Business Overview
13.12.5 Advanced Accelerator Applications Latest Developments
13.13 SIEMENS
13.13.1 SIEMENS Company Information
13.13.2 SIEMENS Radiopharmaceutical Product Portfolios and Specifications
13.13.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 SIEMENS Main Business Overview
13.13.5 SIEMENS Latest Developments
13.14 Dongcheng
13.14.1 Dongcheng Company Information
13.14.2 Dongcheng Radiopharmaceutical Product Portfolios and Specifications
13.14.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Dongcheng Main Business Overview
13.14.5 Dongcheng Latest Developments
13.15 Navidea
13.15.1 Navidea Company Information
13.15.2 Navidea Radiopharmaceutical Product Portfolios and Specifications
13.15.3 Navidea Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Navidea Main Business Overview
13.15.5 Navidea Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiopharmaceutical Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Radiopharmaceutical Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Actinium-225
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Radium-223
Table 6. Major Players of Holmium-166
Table 7. Major Players of Other
Table 8. Global Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 9. Global Radiopharmaceutical Sales Market Share by Type (2019-2024)
Table 10. Global Radiopharmaceutical Revenue by Type (2019-2024) & ($ million)
Table 11. Global Radiopharmaceutical Revenue Market Share by Type (2019-2024)
Table 12. Global Radiopharmaceutical Sale Price by Type (2019-2024) & (USD/Dose)
Table 13. Global Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 14. Global Radiopharmaceutical Sales Market Share by Application (2019-2024)
Table 15. Global Radiopharmaceutical Revenue by Application (2019-2024)
Table 16. Global Radiopharmaceutical Revenue Market Share by Application (2019-2024)
Table 17. Global Radiopharmaceutical Sale Price by Application (2019-2024) & (USD/Dose)
Table 18. Global Radiopharmaceutical Sales by Company (2019-2024) & (M Doses)
Table 19. Global Radiopharmaceutical Sales Market Share by Company (2019-2024)
Table 20. Global Radiopharmaceutical Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Radiopharmaceutical Revenue Market Share by Company (2019-2024)
Table 22. Global Radiopharmaceutical Sale Price by Company (2019-2024) & (USD/Dose)
Table 23. Key Manufacturers Radiopharmaceutical Producing Area Distribution and Sales Area
Table 24. Players Radiopharmaceutical Products Offered
Table 25. Radiopharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Radiopharmaceutical Sales by Geographic Region (2019-2024) & (M Doses)
Table 29. Global Radiopharmaceutical Sales Market Share Geographic Region (2019-2024)
Table 30. Global Radiopharmaceutical Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Radiopharmaceutical Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Radiopharmaceutical Sales by Country/Region (2019-2024) & (M Doses)
Table 33. Global Radiopharmaceutical Sales Market Share by Country/Region (2019-2024)
Table 34. Global Radiopharmaceutical Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Radiopharmaceutical Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 37. Americas Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 38. Americas Radiopharmaceutical Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Radiopharmaceutical Revenue Market Share by Country (2019-2024)
Table 40. Americas Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 41. Americas Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 42. APAC Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 43. APAC Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 44. APAC Radiopharmaceutical Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Radiopharmaceutical Revenue Market Share by Region (2019-2024)
Table 46. APAC Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 47. APAC Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 48. Europe Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 49. Europe Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 50. Europe Radiopharmaceutical Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Radiopharmaceutical Revenue Market Share by Country (2019-2024)
Table 52. Europe Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 53. Europe Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 54. Middle East & Africa Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 55. Middle East & Africa Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Radiopharmaceutical Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 59. Middle East & Africa Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 60. Key Market Drivers & Growth Opportunities of Radiopharmaceutical
Table 61. Key Market Challenges & Risks of Radiopharmaceutical
Table 62. Key Industry Trends of Radiopharmaceutical
Table 63. Radiopharmaceutical Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Radiopharmaceutical Distributors List
Table 66. Radiopharmaceutical Customer List
Table 67. Global Radiopharmaceutical Sales Forecast by Region (2025-2030) & (M Doses)
Table 68. Global Radiopharmaceutical Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 70. Americas Radiopharmaceutical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Radiopharmaceutical Sales Forecast by Region (2025-2030) & (M Doses)
Table 72. APAC Radiopharmaceutical Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 74. Europe Radiopharmaceutical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 76. Middle East & Africa Radiopharmaceutical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Radiopharmaceutical Sales Forecast by Type (2025-2030) & (M Doses)
Table 78. Global Radiopharmaceutical Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Radiopharmaceutical Sales Forecast by Application (2025-2030) & (M Doses)
Table 80. Global Radiopharmaceutical Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Bracco Imaging Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 82. Bracco Imaging Radiopharmaceutical Product Portfolios and Specifications
Table 83. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 84. Bracco Imaging Main Business
Table 85. Bracco Imaging Latest Developments
Table 86. Bayer Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer Radiopharmaceutical Product Portfolios and Specifications
Table 88. Bayer Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Mallinckrodt Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 92. Mallinckrodt Radiopharmaceutical Product Portfolios and Specifications
Table 93. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 94. Mallinckrodt Main Business
Table 95. Mallinckrodt Latest Developments
Table 96. Nordion Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 97. Nordion Radiopharmaceutical Product Portfolios and Specifications
Table 98. Nordion Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 99. Nordion Main Business
Table 100. Nordion Latest Developments
Table 101. Triad Isotopes Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 102. Triad Isotopes Radiopharmaceutical Product Portfolios and Specifications
Table 103. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 104. Triad Isotopes Main Business
Table 105. Triad Isotopes Latest Developments
Table 106. Lantheus Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 107. Lantheus Radiopharmaceutical Product Portfolios and Specifications
Table 108. Lantheus Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 109. Lantheus Main Business
Table 110. Lantheus Latest Developments
Table 111. IBA Group Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 112. IBA Group Radiopharmaceutical Product Portfolios and Specifications
Table 113. IBA Group Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 114. IBA Group Main Business
Table 115. IBA Group Latest Developments
Table 116. GE Healthcare Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 117. GE Healthcare Radiopharmaceutical Product Portfolios and Specifications
Table 118. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 119. GE Healthcare Main Business
Table 120. GE Healthcare Latest Developments
Table 121. China Isotope & Radiation Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 122. China Isotope & Radiation Radiopharmaceutical Product Portfolios and Specifications
Table 123. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 124. China Isotope & Radiation Main Business
Table 125. China Isotope & Radiation Latest Developments
Table 126. Jubilant Pharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 127. Jubilant Pharma Radiopharmaceutical Product Portfolios and Specifications
Table 128. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 129. Jubilant Pharma Main Business
Table 130. Jubilant Pharma Latest Developments
Table 131. Eli Lilly Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 132. Eli Lilly Radiopharmaceutical Product Portfolios and Specifications
Table 133. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 134. Eli Lilly Main Business
Table 135. Eli Lilly Latest Developments
Table 136. Advanced Accelerator Applications Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 137. Advanced Accelerator Applications Radiopharmaceutical Product Portfolios and Specifications
Table 138. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 139. Advanced Accelerator Applications Main Business
Table 140. Advanced Accelerator Applications Latest Developments
Table 141. SIEMENS Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 142. SIEMENS Radiopharmaceutical Product Portfolios and Specifications
Table 143. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 144. SIEMENS Main Business
Table 145. SIEMENS Latest Developments
Table 146. Dongcheng Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 147. Dongcheng Radiopharmaceutical Product Portfolios and Specifications
Table 148. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 149. Dongcheng Main Business
Table 150. Dongcheng Latest Developments
Table 151. Navidea Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 152. Navidea Radiopharmaceutical Product Portfolios and Specifications
Table 153. Navidea Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 154. Navidea Main Business
Table 155. Navidea Latest Developments
Table 1. Radiopharmaceutical Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Radiopharmaceutical Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Actinium-225
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Radium-223
Table 6. Major Players of Holmium-166
Table 7. Major Players of Other
Table 8. Global Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 9. Global Radiopharmaceutical Sales Market Share by Type (2019-2024)
Table 10. Global Radiopharmaceutical Revenue by Type (2019-2024) & ($ million)
Table 11. Global Radiopharmaceutical Revenue Market Share by Type (2019-2024)
Table 12. Global Radiopharmaceutical Sale Price by Type (2019-2024) & (USD/Dose)
Table 13. Global Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 14. Global Radiopharmaceutical Sales Market Share by Application (2019-2024)
Table 15. Global Radiopharmaceutical Revenue by Application (2019-2024)
Table 16. Global Radiopharmaceutical Revenue Market Share by Application (2019-2024)
Table 17. Global Radiopharmaceutical Sale Price by Application (2019-2024) & (USD/Dose)
Table 18. Global Radiopharmaceutical Sales by Company (2019-2024) & (M Doses)
Table 19. Global Radiopharmaceutical Sales Market Share by Company (2019-2024)
Table 20. Global Radiopharmaceutical Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Radiopharmaceutical Revenue Market Share by Company (2019-2024)
Table 22. Global Radiopharmaceutical Sale Price by Company (2019-2024) & (USD/Dose)
Table 23. Key Manufacturers Radiopharmaceutical Producing Area Distribution and Sales Area
Table 24. Players Radiopharmaceutical Products Offered
Table 25. Radiopharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Radiopharmaceutical Sales by Geographic Region (2019-2024) & (M Doses)
Table 29. Global Radiopharmaceutical Sales Market Share Geographic Region (2019-2024)
Table 30. Global Radiopharmaceutical Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Radiopharmaceutical Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Radiopharmaceutical Sales by Country/Region (2019-2024) & (M Doses)
Table 33. Global Radiopharmaceutical Sales Market Share by Country/Region (2019-2024)
Table 34. Global Radiopharmaceutical Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Radiopharmaceutical Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 37. Americas Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 38. Americas Radiopharmaceutical Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Radiopharmaceutical Revenue Market Share by Country (2019-2024)
Table 40. Americas Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 41. Americas Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 42. APAC Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 43. APAC Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 44. APAC Radiopharmaceutical Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Radiopharmaceutical Revenue Market Share by Region (2019-2024)
Table 46. APAC Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 47. APAC Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 48. Europe Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 49. Europe Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 50. Europe Radiopharmaceutical Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Radiopharmaceutical Revenue Market Share by Country (2019-2024)
Table 52. Europe Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 53. Europe Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 54. Middle East & Africa Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 55. Middle East & Africa Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Radiopharmaceutical Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 59. Middle East & Africa Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 60. Key Market Drivers & Growth Opportunities of Radiopharmaceutical
Table 61. Key Market Challenges & Risks of Radiopharmaceutical
Table 62. Key Industry Trends of Radiopharmaceutical
Table 63. Radiopharmaceutical Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Radiopharmaceutical Distributors List
Table 66. Radiopharmaceutical Customer List
Table 67. Global Radiopharmaceutical Sales Forecast by Region (2025-2030) & (M Doses)
Table 68. Global Radiopharmaceutical Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 70. Americas Radiopharmaceutical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Radiopharmaceutical Sales Forecast by Region (2025-2030) & (M Doses)
Table 72. APAC Radiopharmaceutical Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 74. Europe Radiopharmaceutical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 76. Middle East & Africa Radiopharmaceutical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Radiopharmaceutical Sales Forecast by Type (2025-2030) & (M Doses)
Table 78. Global Radiopharmaceutical Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Radiopharmaceutical Sales Forecast by Application (2025-2030) & (M Doses)
Table 80. Global Radiopharmaceutical Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Bracco Imaging Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 82. Bracco Imaging Radiopharmaceutical Product Portfolios and Specifications
Table 83. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 84. Bracco Imaging Main Business
Table 85. Bracco Imaging Latest Developments
Table 86. Bayer Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer Radiopharmaceutical Product Portfolios and Specifications
Table 88. Bayer Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Mallinckrodt Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 92. Mallinckrodt Radiopharmaceutical Product Portfolios and Specifications
Table 93. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 94. Mallinckrodt Main Business
Table 95. Mallinckrodt Latest Developments
Table 96. Nordion Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 97. Nordion Radiopharmaceutical Product Portfolios and Specifications
Table 98. Nordion Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 99. Nordion Main Business
Table 100. Nordion Latest Developments
Table 101. Triad Isotopes Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 102. Triad Isotopes Radiopharmaceutical Product Portfolios and Specifications
Table 103. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 104. Triad Isotopes Main Business
Table 105. Triad Isotopes Latest Developments
Table 106. Lantheus Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 107. Lantheus Radiopharmaceutical Product Portfolios and Specifications
Table 108. Lantheus Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 109. Lantheus Main Business
Table 110. Lantheus Latest Developments
Table 111. IBA Group Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 112. IBA Group Radiopharmaceutical Product Portfolios and Specifications
Table 113. IBA Group Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 114. IBA Group Main Business
Table 115. IBA Group Latest Developments
Table 116. GE Healthcare Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 117. GE Healthcare Radiopharmaceutical Product Portfolios and Specifications
Table 118. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 119. GE Healthcare Main Business
Table 120. GE Healthcare Latest Developments
Table 121. China Isotope & Radiation Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 122. China Isotope & Radiation Radiopharmaceutical Product Portfolios and Specifications
Table 123. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 124. China Isotope & Radiation Main Business
Table 125. China Isotope & Radiation Latest Developments
Table 126. Jubilant Pharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 127. Jubilant Pharma Radiopharmaceutical Product Portfolios and Specifications
Table 128. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 129. Jubilant Pharma Main Business
Table 130. Jubilant Pharma Latest Developments
Table 131. Eli Lilly Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 132. Eli Lilly Radiopharmaceutical Product Portfolios and Specifications
Table 133. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 134. Eli Lilly Main Business
Table 135. Eli Lilly Latest Developments
Table 136. Advanced Accelerator Applications Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 137. Advanced Accelerator Applications Radiopharmaceutical Product Portfolios and Specifications
Table 138. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 139. Advanced Accelerator Applications Main Business
Table 140. Advanced Accelerator Applications Latest Developments
Table 141. SIEMENS Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 142. SIEMENS Radiopharmaceutical Product Portfolios and Specifications
Table 143. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 144. SIEMENS Main Business
Table 145. SIEMENS Latest Developments
Table 146. Dongcheng Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 147. Dongcheng Radiopharmaceutical Product Portfolios and Specifications
Table 148. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 149. Dongcheng Main Business
Table 150. Dongcheng Latest Developments
Table 151. Navidea Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 152. Navidea Radiopharmaceutical Product Portfolios and Specifications
Table 153. Navidea Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 154. Navidea Main Business
Table 155. Navidea Latest Developments
LIST OF FIGURES
Figure 1. Picture of Radiopharmaceutical
Figure 2. Radiopharmaceutical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceutical Sales Growth Rate 2019-2030 (M Doses)
Figure 7. Global Radiopharmaceutical Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Radiopharmaceutical Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Actinium-225
Figure 10. Product Picture of Lutetium-177
Figure 11. Product Picture of Radium-223
Figure 12. Product Picture of Holmium-166
Figure 13. Product Picture of Other
Figure 14. Global Radiopharmaceutical Sales Market Share by Type in 2023
Figure 15. Global Radiopharmaceutical Revenue Market Share by Type (2019-2024)
Figure 16. Radiopharmaceutical Consumed in Oncology
Figure 17. Global Radiopharmaceutical Market: Oncology (2019-2024) & (M Doses)
Figure 18. Radiopharmaceutical Consumed in Cardiology
Figure 19. Global Radiopharmaceutical Market: Cardiology (2019-2024) & (M Doses)
Figure 20. Radiopharmaceutical Consumed in Other
Figure 21. Global Radiopharmaceutical Market: Other (2019-2024) & (M Doses)
Figure 22. Global Radiopharmaceutical Sales Market Share by Application (2023)
Figure 23. Global Radiopharmaceutical Revenue Market Share by Application in 2023
Figure 24. Radiopharmaceutical Sales Market by Company in 2023 (M Doses)
Figure 25. Global Radiopharmaceutical Sales Market Share by Company in 2023
Figure 26. Radiopharmaceutical Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Radiopharmaceutical Revenue Market Share by Company in 2023
Figure 28. Global Radiopharmaceutical Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Radiopharmaceutical Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Radiopharmaceutical Sales 2019-2024 (M Doses)
Figure 31. Americas Radiopharmaceutical Revenue 2019-2024 ($ Millions)
Figure 32. APAC Radiopharmaceutical Sales 2019-2024 (M Doses)
Figure 33. APAC Radiopharmaceutical Revenue 2019-2024 ($ Millions)
Figure 34. Europe Radiopharmaceutical Sales 2019-2024 (M Doses)
Figure 35. Europe Radiopharmaceutical Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Radiopharmaceutical Sales 2019-2024 (M Doses)
Figure 37. Middle East & Africa Radiopharmaceutical Revenue 2019-2024 ($ Millions)
Figure 38. Americas Radiopharmaceutical Sales Market Share by Country in 2023
Figure 39. Americas Radiopharmaceutical Revenue Market Share by Country in 2023
Figure 40. Americas Radiopharmaceutical Sales Market Share by Type (2019-2024)
Figure 41. Americas Radiopharmaceutical Sales Market Share by Application (2019-2024)
Figure 42. United States Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Radiopharmaceutical Sales Market Share by Region in 2023
Figure 47. APAC Radiopharmaceutical Revenue Market Share by Regions in 2023
Figure 48. APAC Radiopharmaceutical Sales Market Share by Type (2019-2024)
Figure 49. APAC Radiopharmaceutical Sales Market Share by Application (2019-2024)
Figure 50. China Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Radiopharmaceutical Sales Market Share by Country in 2023
Figure 58. Europe Radiopharmaceutical Revenue Market Share by Country in 2023
Figure 59. Europe Radiopharmaceutical Sales Market Share by Type (2019-2024)
Figure 60. Europe Radiopharmaceutical Sales Market Share by Application (2019-2024)
Figure 61. Germany Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Radiopharmaceutical Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Radiopharmaceutical Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Radiopharmaceutical Sales Market Share by Application (2019-2024)
Figure 70. Egypt Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Radiopharmaceutical in 2023
Figure 76. Manufacturing Process Analysis of Radiopharmaceutical
Figure 77. Industry Chain Structure of Radiopharmaceutical
Figure 78. Channels of Distribution
Figure 79. Global Radiopharmaceutical Sales Market Forecast by Region (2025-2030)
Figure 80. Global Radiopharmaceutical Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Radiopharmaceutical Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Radiopharmaceutical Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Radiopharmaceutical Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Radiopharmaceutical Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Radiopharmaceutical
Figure 2. Radiopharmaceutical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceutical Sales Growth Rate 2019-2030 (M Doses)
Figure 7. Global Radiopharmaceutical Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Radiopharmaceutical Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Actinium-225
Figure 10. Product Picture of Lutetium-177
Figure 11. Product Picture of Radium-223
Figure 12. Product Picture of Holmium-166
Figure 13. Product Picture of Other
Figure 14. Global Radiopharmaceutical Sales Market Share by Type in 2023
Figure 15. Global Radiopharmaceutical Revenue Market Share by Type (2019-2024)
Figure 16. Radiopharmaceutical Consumed in Oncology
Figure 17. Global Radiopharmaceutical Market: Oncology (2019-2024) & (M Doses)
Figure 18. Radiopharmaceutical Consumed in Cardiology
Figure 19. Global Radiopharmaceutical Market: Cardiology (2019-2024) & (M Doses)
Figure 20. Radiopharmaceutical Consumed in Other
Figure 21. Global Radiopharmaceutical Market: Other (2019-2024) & (M Doses)
Figure 22. Global Radiopharmaceutical Sales Market Share by Application (2023)
Figure 23. Global Radiopharmaceutical Revenue Market Share by Application in 2023
Figure 24. Radiopharmaceutical Sales Market by Company in 2023 (M Doses)
Figure 25. Global Radiopharmaceutical Sales Market Share by Company in 2023
Figure 26. Radiopharmaceutical Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Radiopharmaceutical Revenue Market Share by Company in 2023
Figure 28. Global Radiopharmaceutical Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Radiopharmaceutical Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Radiopharmaceutical Sales 2019-2024 (M Doses)
Figure 31. Americas Radiopharmaceutical Revenue 2019-2024 ($ Millions)
Figure 32. APAC Radiopharmaceutical Sales 2019-2024 (M Doses)
Figure 33. APAC Radiopharmaceutical Revenue 2019-2024 ($ Millions)
Figure 34. Europe Radiopharmaceutical Sales 2019-2024 (M Doses)
Figure 35. Europe Radiopharmaceutical Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Radiopharmaceutical Sales 2019-2024 (M Doses)
Figure 37. Middle East & Africa Radiopharmaceutical Revenue 2019-2024 ($ Millions)
Figure 38. Americas Radiopharmaceutical Sales Market Share by Country in 2023
Figure 39. Americas Radiopharmaceutical Revenue Market Share by Country in 2023
Figure 40. Americas Radiopharmaceutical Sales Market Share by Type (2019-2024)
Figure 41. Americas Radiopharmaceutical Sales Market Share by Application (2019-2024)
Figure 42. United States Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Radiopharmaceutical Sales Market Share by Region in 2023
Figure 47. APAC Radiopharmaceutical Revenue Market Share by Regions in 2023
Figure 48. APAC Radiopharmaceutical Sales Market Share by Type (2019-2024)
Figure 49. APAC Radiopharmaceutical Sales Market Share by Application (2019-2024)
Figure 50. China Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Radiopharmaceutical Sales Market Share by Country in 2023
Figure 58. Europe Radiopharmaceutical Revenue Market Share by Country in 2023
Figure 59. Europe Radiopharmaceutical Sales Market Share by Type (2019-2024)
Figure 60. Europe Radiopharmaceutical Sales Market Share by Application (2019-2024)
Figure 61. Germany Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Radiopharmaceutical Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Radiopharmaceutical Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Radiopharmaceutical Sales Market Share by Application (2019-2024)
Figure 70. Egypt Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Radiopharmaceutical Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Radiopharmaceutical in 2023
Figure 76. Manufacturing Process Analysis of Radiopharmaceutical
Figure 77. Industry Chain Structure of Radiopharmaceutical
Figure 78. Channels of Distribution
Figure 79. Global Radiopharmaceutical Sales Market Forecast by Region (2025-2030)
Figure 80. Global Radiopharmaceutical Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Radiopharmaceutical Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Radiopharmaceutical Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Radiopharmaceutical Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Radiopharmaceutical Revenue Market Share Forecast by Application (2025-2030)
